Pharma firm sets 2050 climate plan favoring PPAs over offsets

Subcontractors and distribution are the sore spots for Lundbeck's ability to met new climate goals of carbon neutrality, but CEO Deborah Dunsire is confident the firm can meet its goal before 2050.
Photo: BeGreen
Photo: BeGreen
BY ELIZABETH MØNSTED JOHANSEN, MEDWATCH

Lundbeck's goal to become carbon neutral by 2050 heavily leans on the global Paris Agreement, but the pharmaceutical companies plans to reach this target before then, says Lundbeck CEO Deborah Dunsire in the wake of the company presenting its new climate plan.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    On June 1, Senvion's former CFO Manav Sharma started as US country manager for Nordex. Soon he will have a new factory at his disposal. | Foto: Senvion

    Nordex restarts production in the US

    For subscribers

    Further reading